Biolevate Integrates NVIDIA BioNeMo Toolkit for AI Drug Discovery

June 26, 2026
Biolevate is integrating NVIDIA BioNeMo Agent Toolkit and GPU-optimized pipelines into its OCEAN technology stack to enhance AI-based drug discovery workflows and improve RNA model predictions.

Biolevate announced in a press release that it is integrating the NVIDIA BioNeMo Agent Toolkit and GPU optimized pipelines into its drug discovery technology stack. The Paris-based company aims to expand its agentic discovery roadmap and strengthen its OCEAN platform, which supports workflows across scientific literature, biological knowledge graphs, computational models, and experimental processes.

The integration builds on Biolevate's use of NVIDIA accelerated computing to fine-tune AI agents for clinical and regulatory applications. The company is now developing advanced RNA-focused models to improve predictions of non-coding RNA folding and hybridization, which could enhance patient stratification and precision medicine.

Biolevate also plans to align parts of its OCEAN stack with NVIDIA Nemotron and BioNeMo open source models. This step is expected to make its platform more interoperable within the broader research ecosystem and support the creation of agentic AI systems capable of reasoning across biological data and experimental workflows.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

06/26
LG CNS Expands Global Reach with Agentic AI ERP Testing Platform
06/26
Pittco Invests in UK AI Data Center Firm Nscale
06/26
MRI Software Introduces Agora Intelligence and Orchestrator for AI Workflow Automation in Real Estate
06/26
Seekr and SNC Partner to Develop AI for Multi Domain Defense Missions
06/26
Omnicom Media and NBCUniversal Introduce Dynamic Contextual Advertising for Streaming

More from: Life Sciences

06/26
UpDoc Receives FDA Clearance for Clinical AI Platform
06/26
Aidoc Receives FDA Breakthrough Designation for AI Radiology Report Drafting
06/26
Upside Raises $20 Million Series A to Expand AI Supported Housing Platform for Healthcare
06/26
Clairyon AI Agent Shown to Improve Sepsis Care Compliance in JAMA Study
06/26
Veeva Systems Introduces Veeva EHS for Environmental, Health, and Safety Management

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like